Skip to content
facebook
twitter
linkedin
THERADNET
International Network for Training and Innovation in Therapeutic Radiation
  • HOME
  • Network
    • EARLY STAGE RESEARCHERS
    • PARTNERS
    • MANAGEMENT TEAM
    • ASSOCIATED PARTNERS
    • ADVISORY BOARD
    • BENEFICIARY SITES
  • Science
    • Research Projects
      • TUMOR SENSITIZATION
      • NORMAL TISSUE PROTECTION
      • ADAPTATION AND ESCAPE
    • PUBLICATIONS
  • TRAININGS
  • Contact
  • Meetings & Workshops
    • MEETINGS
    • WORKSHOPS
  • Intranet

Latest News
2nd THERADNET Workshop (24-26 Nov 2020)
In November 2020, the 2nd Workshop took place – again online, from24th to 26th November 2020: Topics: “Clinical and pre-clinical...
1st THERADNET Workshop (6-8 July 2020)
Following the kick-off meeting in Brussels, the first Workshop took place from 6th to 8th July 2020, due to the...
Research Data Management course (25th and 26th November 2020)
As part of the 2nd THERADNET workshop, ESRs took part in a Research Data Management Course headed by Dr. Stefanie...
Video Pitch Workshop by Maris et al. (October 2020)
All ESRs received training in pitching themselves and their projects to specific audience, in this case the general public. During...
ESTRO Research Course in Translational Radiation Biology and Oncology (November 8th to 11th 2020)
In October 2020, all ESRs participated at the ESTRO- organized “Research Course in Translational Radiation Biology” This course was aimed...


The THERADNET project is an innovative training network with the goal to integrate novel-emerging tumor-biological concepts into current standard-of-care to improve the outcome of radiotherapy-treated cancer patients. Approximately 50% of all cancer patients in Europe have an indication for radiotherapy at least once during the course of their disease, with an absolute number of patients steadily increasing assuming overall cancer rates remain unchanged. Advances in the modern radiotherapy could greatly increase chances of surviving cancer and improve the quality of life of treated patients.

THERADNET improves collaborative scientific action for researchers interested in radiotherapy. THERADNET covers a research program across 21 academic and non-academic, industry partners and brings together a multidisciplinary faculty of scientists and research-oriented clinicians who are well qualified and experienced in supervision.

THERADNET will prepare a new generation of highly competent and translational research-oriented early-stage researchers to expedite discovery and clinical translation in radiation research and oncology.  With a view to finding novel strategies to cure cancer through radiotherapy, THERADNET will integrate novel radiobiological insights into clinical and technological approaches.

Funding

This project has received funding from the European Union’s Horizon 2020  research and innovation programme under the Marie Skłodowska-Curie grant agreement No 860245

Contact

THERADNET
Martin Pruschy
Laboratory for Applied Radiobiology
Dept. of Radiation Oncology
University Hospital Zurich
theradnet@physiol.uzh.ch

Follow our blog

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

© 2021 THERADNET